Publications by authors named "S E C Stein"

The first year postpartum is a sensitive time for maternal eating behaviors including emotional, external and restrained eating, which have all been associated with negative health outcomes. Furthermore, among women with a history of trauma, the stress of the postpartum period and early parenting may replicate feelings of helplessness and overwhelm experienced during childhood trauma, which may further contribute to these eating behaviors. Although evidence has shown how mothers eat during this time has long-term implications for infants' eating and health, limited research has characterized eating trajectories and associations with women's history of childhood trauma exposure during this critical period.

View Article and Find Full Text PDF

The objective was to test the generalisability of electroencephalography (EEG) markers of future pain using two independent datasets. Datasets, A [N = 20] and B [N = 35], were collected from participants with subacute spinal cord injury who did not have neuropathic pain at the time of recording. In both datasets, some participants developed pain within six months, (PDP) will others did not (PNP).

View Article and Find Full Text PDF

Background: COVID-19 increased the burden of childcare on parents, leaving women vulnerable to increased disparities in the division of domestic labor. Women healthcare workers may be at heightened risk of worsening gender parity in the workplace as a result.

Objective: To examine the impact of the COVID-19 pandemic on gender parity in the division of household responsibilities among women healthcare workers.

View Article and Find Full Text PDF

While gas chromatography mass spectrometry (GC-MS) has long been used to identify compounds in complex mixtures, this process is often subjective and time-consuming and leaves a large fraction of seemingly good-quality spectra unidentified. In this work, we describe a set of new mass spectral library-based methods to assist compound identification in complex mixtures. These methods employ mass spectral uniqueness and compound ubiquity of library entries alongside noise reduction and automated comparison of retention indices to library compounds.

View Article and Find Full Text PDF

Background: Nivolumab-based therapies are efficacious with acceptable safety in patients with gastric cancer (GC) and gastroesophageal junction cancer (GEJC). Novel nivolumab-based combination immunotherapies may offer enhanced efficacy in these indications. FRACTION-GC was a signal-seeking, randomized, open-label, phase II adaptive-design trial assessing efficacy and safety of nivolumab in combination with ipilimumab [cytotoxic T lymphocyte antigen-4 (CTLA-4) antibody], relatlimab (lymphocyte-activation gene 3 antibody), or IDO1i (BMS986205, an indoleamine-2,3-dioxygenase-1 inhibitor) in patients with unresectable, advanced/metastatic GC/GEJC.

View Article and Find Full Text PDF